This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Roche's patent appeal leaves India's generic Risdiplam launch in limbo

By Freny Patel ( April 9, 2025, 05:05 GMT | Insight) -- The ongoing patent battle between Roche and Natco Pharma over Risdiplam, a crucial drug for spinal muscular atrophy, highlights the tension between protecting pharmaceutical innovation and ensuring patents have affordable access to essential medicines, particularly in India where public health concerns are often prioritized. Roche is appealing a ruling last month where the Delhi High Court sided with public interest by denying Roche's plea to block Natco from producing a generic version of Risdiplam. The court found the potential for broader access to the life-saving drug at an affordable price outweighed Roche's patent rights, for which the company could be compensated monetarily. The legal battle between Swiss pharmaceutical giant F. Hoffmann-La Roche and Indian drugmaker Natco Pharma over the generic production of Risdiplam, which will be the subject of an appeal today, illustrates the conflict between the protection of pharmaceutical patent rights and the urgent need for affordable access to critical healthcare in India....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections